eanCast: Weekly Neurology

Moderator: Theodoros Mavridis (Dublin, Ireland)

Guest: David Seiffge (Bern, Switzerland)

In this episode, Theodoros Mavridis speaks with guest David Seiffge about breakthrough strokes, a challenging condition where ischemic strokes occur despite the use of antithrombotic therapies. They explore the diagnostic process, investigating compliance, and identifying competing etiologies. Prof. Seiffge also discusses potential treatment options, including emerging therapies like Factor 11 inhibitors and left atrial appendage closure, offering insights into ongoing trials aimed at improving patient outcomes.

Moderator: Benedetta Storti (San Donà di Piave, Italy)

Guest: Charlotte Cordonnier (Lille, France)

Join Benedetta Storti and Charlotte Cordonnier for a discussion on the acute management of intracerebral hemorrhage. Discover the latest European Stroke Organization guidelines, the importance of timely intervention, and the evolving role of reversal agents and surgical approaches in stroke care.

Moderator: Mathilde Leonardi (Milan, Italy)

Guests: Sanja Gluscevic (Podgorica, Montenegro), Simone Salemme (Modena, Italy)

This episode explores how early-career neurologists can bridge science, policy, and society through advocacy—highlighting real examples of how EAN Brain Health Ambassadors are translating brain health into action both within and beyond clinical practice.

Becoming a certified Brain Health Ambassador through the EAN's Advocacy Training programme offers neurologists the chance to advance brain health by gaining the knowledge and practical skills needed to advocate effectively at local, national, and European levels. As part of the training, participants will explore the principles of effective advocacy, develop communication...

Moderator: Alice Accorroni (Geneva, Switzerland)

Guests: James Teo (London, UK), Giuseppe Jurman (Trento, Italy)

In this special episode, Dr Alice Accorroni is joined by Professor James Teo and Professor Giuseppe Jurman to discuss the impact of artificial intelligence in neurology: They analyse the actual improvements provided by its adoption, the factors that are hindering this same adoption, especially in a clinical setting, the potential future landscape clinicians and data scientists will be facing and how neurologists' attitude can be oriented more favourably towards new AI solutions.